AU2001248173A1 - Use of uric acid or precursors thereof as a treatment for cancer, aids and the like - Google Patents
Use of uric acid or precursors thereof as a treatment for cancer, aids and the likeInfo
- Publication number
- AU2001248173A1 AU2001248173A1 AU2001248173A AU4817301A AU2001248173A1 AU 2001248173 A1 AU2001248173 A1 AU 2001248173A1 AU 2001248173 A AU2001248173 A AU 2001248173A AU 4817301 A AU4817301 A AU 4817301A AU 2001248173 A1 AU2001248173 A1 AU 2001248173A1
- Authority
- AU
- Australia
- Prior art keywords
- precursors
- aids
- cancer
- treatment
- uric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002304869A CA2304869A1 (en) | 2000-04-07 | 2000-04-07 | Method of medical treatment using uric acid or precursors thereof |
CA2,304,869 | 2000-04-07 | ||
PCT/CA2001/000457 WO2001076606A2 (en) | 2000-04-07 | 2001-04-04 | Use of uric acid or precursors thereof as a treatment for cancer, aids and the like |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001248173A1 true AU2001248173A1 (en) | 2001-10-23 |
Family
ID=4165836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248173A Abandoned AU2001248173A1 (en) | 2000-04-07 | 2001-04-04 | Use of uric acid or precursors thereof as a treatment for cancer, aids and the like |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001248173A1 (en) |
CA (1) | CA2304869A1 (en) |
WO (1) | WO2001076606A2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
WO1997039352A1 (en) * | 1996-04-15 | 1997-10-23 | Fox Chase Cancer Center | Assays for detection of purine metabolites |
US5872124A (en) * | 1996-07-31 | 1999-02-16 | Thomas Jefferson University | Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite |
CA2339004C (en) * | 1998-07-31 | 2008-04-01 | Hme Enterprises, Llc | Antioxidant composition and method of treating diseases using same |
-
2000
- 2000-04-07 CA CA002304869A patent/CA2304869A1/en not_active Abandoned
-
2001
- 2001-04-04 AU AU2001248173A patent/AU2001248173A1/en not_active Abandoned
- 2001-04-04 WO PCT/CA2001/000457 patent/WO2001076606A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2304869A1 (en) | 2001-10-07 |
WO2001076606A2 (en) | 2001-10-18 |
WO2001076606A3 (en) | 2002-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223827A1 (en) | Well treatment | |
AU2001265253A1 (en) | Treatment of hiv using hyperthermia | |
AU2002213887A1 (en) | Process for the antimicrobial treatment of fiber materials | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU2002231206A1 (en) | Treatment of depression | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2002322481A1 (en) | Use of r-nsaid compounds for anti-hiv treatment | |
AU2001293891A1 (en) | New combination for the treatment of asthma | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU2001245414A1 (en) | Treatment of allergies | |
AU2003291368A1 (en) | Compounds for the treatment of tobacco dependence and withdrawal | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2001248173A1 (en) | Use of uric acid or precursors thereof as a treatment for cancer, aids and the like | |
AU2003295163A1 (en) | Composition for the treatment of hiv or aids | |
AU7756900A (en) | Treatment of chemical hydrolysates | |
AU5824800A (en) | Use of fosphenytoin for the treatment of acute neuropathic pain | |
AU1618901A (en) | Treatment of rosacea | |
MXPA03004454A (en) | Imidazolone derivatives for the treatment of viral diseases. | |
AU2001281465A1 (en) | Treatment of rosacea | |
AU2001282277A1 (en) | Treatment of mycobacterial infection | |
AU2003238414A1 (en) | Use of diuretics for treating swellings | |
AU2001253560A1 (en) | Methods of treatment | |
EP1177789A3 (en) | Use of phytanic acid for the treatment of diabetes | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU2178999A (en) | Preparation of methacrylic acid, derivatives thereof or precursors thereto |